Evidence map›Paper›PMID 37454464›Full record

ArticleThrombosis research2023

DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network.

Karlyn A Martin, Nicola Lancki, Lisa Baumann Kreuziger, Celina Li, M Elaine Eyster, Kristen Sanfilippo, Scott C Woller, Rachel P Rosovsky

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Thrombosis research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Left Ventricular Thrombus in Oncology Patients and Beyond: Imaging, Treatment Choices, and Duration.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Karlyn A MartinDivision of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America. Electronic address: Karlyn.martin@northwestern.edu.
Nicola LanckiNorthwestern University Feinberg School of Medicine, Chicago, IL, United States of America.
Lisa Baumann KreuzigerBlood Research Institute, Versiti, Milwaukee, WI, United States of America; Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, United States of America.
Celina LiDepartment of Medicine, Division of Hematology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
M Elaine EysterMilton S Hershey Medical Center, Penn State College of Medicine, Hershey, PA, United States of America.
Kristen SanfilippoWashington University St. Louis School of Medicine, Saint Louis, MO, United States of America; Saint Louis Veterans Administration Medical Center, Saint Louis, MO, United States of America.
Scott C WollerDepartment of Medicine, Intermountain Medical Center, Murray, UT, United States of America; Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America.
Rachel P RosovskyDepartment of Medicine, Division of Hematology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
Harvard University · USNorthwestern University · USMedical College of Wisconsin · USPenn State Milton S. Hershey Medical Center · USUniversity of Utah · USWashington University in St. Louis · US

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Implementing Prevention of Venous Thromboembolism for Ambulatory Patients with Cancer (PREVenT-APC)K23HL157758 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Karlyn Martin · 2022 to 2026
$831k
NCATS NIH HHS UL1 TR001422NHLBI NIH HHS K23 HL157758
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Venous ThromboembolismWarfarinAdministration, OralAnticoagulantsFactor Xa InhibitorsHumansRetrospective StudiesRivaroxabanAnticoagulantsFactor Xa InhibitorsRivaroxabanWarfarinAnticoagulantsBody mass indexFactor Xa inhibitorsThinnessVenous thromboembolismWarfarin

Identifiers

PMID37454464
PMCPMC12083243
OpenAlexW4383874113

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.